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Abstract
Clear cell chondrosarcoma is a rare variant of chondrosarcoma that mostly involves the end of long bones.
However, nine cases have been reported in the head and neck: four in larynx, two in nasal septum, two in maxilla
and one in the skull. These cases form the basis of this review. Head and neck cases accounts for less than 5% of
Clear cell chondrosarcomas in the whole body and the larynx is the most common place. The histological findings
of head and neck cases are consistent with general features of this entity in the whole body and nearly all tumors
in this case series had a component of conventional chondrosarcoma. Clear cell chondrosarcoma is an
intracompartmental tumor and retains “Grenz zone” just beneath the epithelium. Therefore, the overlying mucosa
remained intact in all laryngeal cases. Nasal tumor caused ballooning of the septum and the maxillary lesion did
not involve the oral mucosa. This tumor presents various radiographic features in the head and neck area.
Chondroblastoma, chondroma, osteoblastoma, osteosarcoma and metastatic renal cell carcinoma are included in
the histologic differential diagnoses. Differentiation from chondroblastic osteosarcoma is important in the maxilla.
A wide resection is adequate in most cases. However, some laryngeal cases show tendency to recur. Clear cell
chondrosarcoma is a slow growing tumor and this necessitates a long time follow-up of patients. Due to the
extreme rarity in the head and neck, diagnosis of Clear cell chondrosarcoma in this area, must be confirmed by
histochemical and immunohistochemical studies.
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Introduction
Approximately 1% to 3% of all chondrosarcomas occur in
the head and neck area and they arise frequently in the
maxilla, mandible, skull, cervical vertebrae, nasal cavity
and larynx [1]. The clear cell chondrosarcoma is an
extremely rare variant of chondrosarcoma that accounts
for about 2% of all chondrosarcomas. This mesenchymal
tumor usually affects the epiphyseal region or apophysis
of the long bones particularly the femur and humerus.
Patients are more in the third, fourth or fifth decade of
life [2]. Local pain is the predominant symptom and the
duration of pain is more than 1.5 years in many cases.
This rare cartilaginous tumor is a low-grade malignancy
that does not invade soft tissues in many cases. However,
“en bloc” resection is the preferred choice of treatment in
all cases. Lesions may recur even after two decades of
first surgical treatment. Lung, brain, and skeleton are the
most probable metastatic locations [3]. A summary of
clinical data for this rare entity is provided in Table 1.
To the best of our knowledge, only nine cases of this
rare entity in the head and neck area have been reported.
These cases form the basis of this review.
Materials and methods
We reviewed MEDLINE-indexed publications using the
keyword “clear cell chondrosarcoma”.W ef o u n dm o r e
than 200 reported cases of clear cell chondrosarcoma in
the literature. Among these cases, nine cases had occurred
in the head and neck area: Four in larynx, two in nasal
septum, two in maxilla and one in skull. Available clinical
and histological data of these cases were extracted from
the relevant articles [4-12] and summarized in Table 2. No
clinical or histological data was available in the articles
[11,12] for two cases of clear cell chondrosarcoma in the
head and neck (case 8, 9).
Results
Clinical features
Three patients were men and three were women. The
median age of patients was approximately 59 years
(range 46-79 years). The duration of symptoms was vari-
able, in a range of 1 month to 3 years. One of laryngeal
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before true diagnosis. This lesion recurred three times
until the diagnosis of clear cell chondrosarcoma was
made [8]. Patients with laryngeal tumors had symptoms
as dyspnea, stridor, hoarseness and change in the neck
shape. The overlying mucosa was intact in all laryngeal
cases. Patients with nasal involvement complained of
nasal obstruction or recurrent epistaxis. There was a
huge ballooning of nasal septum in one case [5]. The
Maxillary lesion presented with a painless enlarging
lesion in the anterior area and the overlying buccal
mucosa was not attached to the tumor [4]. Lymph node
involvement was clinically evident in some cases.
Radiographic appearance
Tumors presented primarily as lobulated, multilocular
or even well-defined cyst like radiolucencies. In laryn-
geal and nasal tumors, areas of intratumoral calcification
were seen. The maxillary lesion was a poorly defined,
osteolytic lesion between the roots of teeth and no root
resorption was seen. Localized thickening of the period-
ontal ligament space is a typical feature of jaw chondro-
sarcoma, but it was not present in this maxillary case
[4].
Gross appearance
The tumor was 10 cm in the greatest diameter [8].
Tumors frequently revealed a prominent firm lobular pat-
tern of growth. They had friable translucent cartilaginous
nodules mixed with soft, gray or blue cut surface similar
to gross appearance of conventional chondrosarcoma.
Histological features
The histological findings were consistent with general fea-
tures of clear cell chondrosarcoma (Figures 1,2) character-
ized by a lobulated (in most cases) neoplasm. Tumors
were made up of uniform to polymorphic densely-packed
large cells, side by side or merging with each other. The
Table 1 A summary of clinical data for clear cell chondrosarcoma
Clear Cell Chondrosarcoma
Clinical Features An extremely rare variant of chondrosarcoma
More in adults between 3-5 decades of life
Male predominance
Usually in the proximal femur and humerus
Long-standing symptoms as pain, pathologic fracture,...
Radiographic appearance Not diagnostic, may mimic giant cell tumor or chondroblastoma
Behavior Low-grade behavior
Clear tendency for late recurrence and metastases
Few cases behave aggressively
Treatment “en bloc” resection
A long time follow-up is necessary
Table 2 Clinical Data of Patients with Head and Neck Clear Cell Chondrosarcoma
Case Age/
sex
Site Symptoms Durationof
symptoms
Treatment Recurrence Further
treatment
Follow
up
1 50/F Maxilla Swelling & slow
enlargement
3 y Local excision No - 10 y
2 79/F Nasal septum Nasal obstruction 6 m Resection No - 16 m
3 62/F Nasal septum Recurrent epistaxis 1 m Wide resection No - 30 m
4 46/
M
Subglottic Dyspnea & Stridor 6 m Laryngectomy No - 6 m
5 61/
M
Subepiglott Dyspnea & Hoarseness History of
chondroma
22 yr before
Laryngectomy&
Neck dissection&
Radiotherapy
No - N/A
6 57/
M
Cricoid
cartilage
Dyspnea - Laryngectomy &
Neck dissection&
Hemithyroidectomy
1-15 m
2-20 m
3-33 m
Locally
removed
3y
7 56/
M
Thyroid
cartilage
1-Voice change
2-Change in neck shape
1-2 yr
2- several mo
Partial resection of
thyroid cartilage
-- 4 y
8 N/A Maxilla N/A N/A N/A N/A N/A N/A
9 N/A Skull N/A N/A N/A N/A N/A N/A
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Page 2 of 5cells had an abundant round to polygonal clear cytoplasm
with small hyperchromatic to large round central nucleus,
lacking production of hyaline chondroid matrix. Various
cellular differentiations of tumor cells were also seen. Fre-
quently, a group of clear cells had a faintly to intensively
acidophilic granular cytoplasm resembling chondroblasts.
Nearly all tumors had a component of conventional chon-
drosarcoma. Characteristically, the cartilage tumor cells in
these fields had produced large amounts of mature chon-
droid matrix with multiple foci of calcification. However,
chondroid matrix formation was rare within the clear cell
component. Multinucleated osteoclast-like giant cells were
present in most cases, but not within the compact fields of
clear cells. The presence of theses giant cells is also absent
in some recently reported cases of clear cell chondrosar-
coma and it is not necessary for diagnosis [13]. The
mitotic rate was very low within all cases. Frequently, irre-
gularly shaped trabeculae of osteoid and woven bone were
scattered throughout the lesions. The tumor cells showed
well-defined pushing borders or infiltration beyond the
organ borders to the surrounding soft or hard tissues.
Small amounts of intracellular glycogen were demon-
strated by positive PAS staining in some cases whereas
some others were negative.
Treatment
Nasal tumors were resected and the maxillary lesion was
locally excised. Laryngectomy was performed in 75% (3 of
4) of laryngeal cases and additional radical neck dissection
was done in 50% (2 of 4). Locally removal of the tumor as
a chondroma before its true diagnosis in case5 led to two
recurrences. Radiotherapy was done in only one case and
the average follow up of patients was 42 month (range
from 6 months to 10 years).
Discussion
Less than 5% (9/200) of reported cases of clear cell chon-
drosarcoma have occurred in the head and neck area,
and although, laryngeal chondrosarcoma is a rare entity,
the larynx is the most common place involved by clear
cell type in the head and neck (44%). The mean age of
reported cases of clear cell chondrosarcoma in the head
and neck is similar to the mean age of chondrosarcoma
in the whole body (60 years). However this differs from
the average age of patients with head and neck chondro-
sarcoma that is mostly 35 to 45 years old [2].
Although a definite male predominance is seen in var-
ious case series of clear cell chondrosarcoma; this pro-
pensity is not observed in this case series of head and
neck. Head and neck clear cell chondrosarcomas have
occurred in alveolar bone, nasal septum and larynx
where are among the common sites of head and neck
chondrosarcoma.
Many clear cell chondrosarcomas are intracompart-
mental rather than extracompartmental; so they expand
the bones without permeating the cortex [14]. They
also, similar to other primary mesenchymal neoplasms,
retain “Grenz zone” of tumor-free superficial submucosa
just beneath the epithelium. Therefore, nasal tumor in
case 2 caused ballooning of the septum; maxillary lesion
did not involve the oral mucosa; and despite the lumen
obstruction by tumor, the overlying mucosa remained
intact in all laryngeal cases.
The radiographic appearance of clear-cell chondrosar-
coma is generally an osteolytic destructive expansive
lesion with sharp margins; however, in larger tumors, the
margins become poorly defined [4]. Punctuate densities
are also occasionally identified within the tumor.
Tumors of this case series in head and neck pre-
sented various radiographic features from unilocular to
Figure 1 Sheet-like arrangement of tumor cells in clear cell
chondrosarcoma. Tumor cells have clear cytoplasm,
hyperchromatic nucleus and distinct cytoplasmic borders.
Figure 2 Ossification within clear cell chondrosarcoma.
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lesions. Intratumoral calcification that was present in
some cases is mostly related to the presence of newly
formed osseous elements. Clear cell chondrosarcoma is
frequently diagnosed as chondroblastoma radiographi-
cally and histologically in literature and could be its
malignant counterpart [15]. Since chondroblastoma has
not been reported in the maxilla or nasal skeleton [4]
the transformation of chondroblastoma to clear cell
chondrosarcoma in cases of maxillofacial skeleton
seems improbable.
Because of osteoid formation, bone-forming lesions such
as osteoblastoma or osteosarcoma are included in the
histologic differential diagnoses [14]. This is mainly impor-
tant in anatomic sites of head and neck that are more
prone to osteosarcoma such as skull, maxilla and mand-
ible. Chondroblastic osteosarcoma is the most common
variant of this tumor in the maxilla and therefore, it is one
of main differential diagnoses of clear cell chondrosarcoma
of maxilla. Osteosarcoma must be differentiated by the
absence of clear cells, the presence of severe nuclear poly-
morphism and atypical mitoses. Three cases of high grade
osteosarcoma with significant areas of clear cells have
been reported [16]. Although extremely rare, but this
entity must also be considered. The other differential diag-
noses, especially in laryngeal neoplasms, include squamous
cell carcinoma and metastatic clear cell carcinoma mainly
renal cell carcinoma [9].
Areas of conventional chondrosarcoma are often present
in cases of clear cell chondrosarcoma and this component
was present in almost all of these cases. Recent findings
indicate that chondroma and chondrosarcoma of the lar-
ynx are closely related and it is well known that distinction
between these two entities could be extremely difficult
[17,18]; similar to the case 5, it is not uncommon for the
biopsy tissue diagnosed as a benign chondroma to be ulti-
mately diagnosed as chondrosarcoma [19]. Since the
occurrence of a true chondroma of the larynx is extremely
rare [2], and because more than 90% of all laryngeal carti-
laginous tumors are chondrosarcomas, cartilage lesions
that are clinically significant or have recurred should be
considered as chondrosarcoma [20,21]. As well, benign
chondrogenic tumors of the jaws are quite rare and benign
appearing cartilaginous tumors in the jaws are considered
potentially malignant.
Wide and aggressive surgical resection is the critical
point in treatment of head and neck chondrosarcoma
and results in a favorable prognosis. Metastases are not
common in head and neck chondrosarcoma [2]. The 5-
year survival rate for chondrosarcoma of the head and
neck varies from 43% to 95% [2]. Clear cell variant is a
distinct low-grade sarcoma with potential for local recur-
rence or distant metastasis. Recurrence rate of 19% has
been described in some case series of this tumor [22]. It
has been stated that regardless of the stage of tumor, a
wide margin of normal bone and soft tissue around the
resected lesion is required to achieve adequate local con-
trol [14]. However, some patients in this series, whose
lesions were treated with local removal, did not devel-
oped local recurrences or metastases. Although proton
beam therapy has been successfully used in the treatment
of head and neck chondrosarcoma [23], its effectiveness
in clear cell variant of head and neck chondrosarcoma
needs more investigation.
The prognosis was excellent in nasal and maxillary
lesions. The absence of root resorption was also consistent
with indolent clinical course of the maxillary tumor.
Recurrence was noted in two laryngeal cases and it seems
that laryngeal tumors have more probability to recur.
Therefore, they need more consideration. Although, total
laryngectomy is reserved for high-grade laryngeal chon-
drosarcomas, some studies indicate that conservative ther-
apeutic approach in conventional chondrosarcoma has
increased the incidence of local recurrence from 77% to
86% [24]. Two of four presented laryngeal cases were trea-
ted with laryngectomy and radical neck dissection and this
was consistent with their clinical course. Nevertheless, the
behavior of all four laryngeal tumors supports the general
experience that chondrosarcomas in the larynx have a
favorable course of disease [24,25]; as well, early correct
diagnosis is important to avoid multiple recurrences [9].
The primary symptoms in clear cell chondrosarcoma are
generally of long duration. 55% of the patients in the lar-
gest series of clear cell chondrosarcoma have symptoms
for more than 1 year [12]. This long duration of symptoms
before diagnosis is consistent with a slow-growing tumor
[14]. One laryngeal tumor (case 5) has an indolent clinical
course over 22 years with multiple recurrences [5]. This
behavior necessitates a long time follow-up of patients to
judge the efficacy of treatment [26].
On the molecular level, recent studies have shown the
presence of extra copies of chromosome 20 and loss or
rearrangements of 9p in clear cell chondrosarcoma. In
addition, expression of PTHLH, PDGFIHH, Runt-related
transcription factor2 [27] have been found. Widespread
positivity for matrix metalloproteinase 2 (MMP2) have
been shown in some reported cases of clear cell chondro-
sarcoma with aggressive clinical behavior [28]. Park et al.
have investigated the role ofp 5 3i nt h ep a t h o g e n e s i so f
this tumor. They showed that a genetic alteration of p53 is
a rare event, whereas its overexpression may occur in a
substantial percentage of clear cell chondrosarcoma [29].
Allelic loss at chromosome 18q21 has been found in the
laryngeal case of clear cell chondrosarcoma. This has not
been described for chondrosarcomas so far [9]. For that
reason, more investigations in future are necessary to
determine the genetics of head and neck clear cell
chondrosarcoma.
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clear cell chondrosarcoma has to be confirmed by light
microscopic appearance, presence of glycogen (in most
cases), expression of S-100 protein and collagen type II,
which is as a characteristic of clear cell chondrosarcoma,
by immunohistochemistry [27]. This allows a reliable diag-
nosis of the rare cases of this tumor in the unusual loca-
tion of head and neck; so, possible overtreatment or
undertreatment of patients will be prevented.
Conclusions
Head and neck clear cell chondrosarcoma accounts for
less than 5% of clear cell chondrosarcoma in the whole
body. Nine cases have been reported in larynx, nasal sep-
tum, maxilla and skull. Larynx is the most common place
involved by this entity in the head and neck. The mean
age of clear cell chondrosarcoma in the head and neck is
similar to that of chondrosarcoma in the whole body.
These tumors present with various radiographic features
in the head and neck. Areas of conventional chondrosar-
coma were present in almost all head and neck cases. His-
tological differential diagnose with other bone forming
lesions such as osteoblastoma or osteosarcoma must be
considered in the head and neck. A wide resection is ade-
quate in most cases. However, some laryngeal cases show
tendency to recur. Due to the extreme rarity of this tumor
in the head and neck, its diagnosis must be confirmed by
histochemical and immunohistochemical studies. There-
fore, possible overtreatment or undertreatment of patients
will be prevented.
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